GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai OPM Biosciences Co Ltd (SHSE:688293) » Definitions » Capital Expenditure

Shanghai OPM Biosciences Co (SHSE:688293) Capital Expenditure : ¥-103.53 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai OPM Biosciences Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shanghai OPM Biosciences Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ¥-7.6 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-103.53 Mil.

Shanghai OPM Biosciences Co Capital Expenditure Historical Data

The historical data trend for Shanghai OPM Biosciences Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai OPM Biosciences Co Capital Expenditure Chart

Shanghai OPM Biosciences Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial -36.24 -99.20 -146.96 -77.55 -120.86

Shanghai OPM Biosciences Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.95 -26.99 -32.21 -36.71 -7.61

Shanghai OPM Biosciences Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-103.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai OPM Biosciences Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai OPM Biosciences Co Ltd (SHSE:688293) » Definitions » Capital Expenditure
Comparable Companies
SHSE:688767 SZSE:300318 SZSE:300497 SHSE:603590 SHSE:603718 SHSE:688253 SZSE:301333 SHSE:688075 BJSE:839273 BJSE:430047 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 28, Lane 908, Ziping Road, Pudong New Area, Shanghai, CHN, 201321
Website
http://www.opmbiosciences.com
Shanghai OPM Biosciences Co Ltd is a biotechnology company focusing on providing cell culture solutions and end-to-end CDMO services.
Executives
Xiao Zhi Hua Director
Ni Liang Ping Director

Shanghai OPM Biosciences Co Headlines

No Headlines